Recombinant Human EXOSC5 protein (ab124595)

Overview

  • Product nameRecombinant Human EXOSC5 protein
  • Protein lengthFull length protein

Description

  • NatureRecombinant
  • SourceEscherichia coli
  • Amino Acid Sequence
    • AccessionQ9NQT4
    • SpeciesHuman
    • SequenceMGSSHHHHHH SSGLVPRGSH MMEEETHTDA KIRAENGTGS SPRGPGCSLR HFACEQNLLS RPDGSASFLQ GDTSVLAGVY GPAEVKVSKE IFNKATLEVI LRPKIGLPGV AEKSRERLIR NTCEAVVLGT LHPRTSITVV LQVVSDAGSL LACCLNAACM ALVDAGVPMR ALFCGVACAL DSDGTLVLDP TSKQEKEARA VLTFALDSVE RKLLMSSTKG LYSDTELQQC LAAAQAASQH VFRFYRESLQ RRYSKS
    • Molecular weight28 kDa including tags
    • Amino acids1 to 235
    • TagsHis tag N-Terminus

Specifications

Our Abpromise guarantee covers the use of ab124595 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    SDS-PAGE

    Mass Spectrometry

  • Mass spectrometry
    MALDI-TOF
  • Purity> 90 % SDS-PAGE.
    ab124595 is purified using conventional chromatography techniques.
  • FormLiquid
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    pH: 7.40
    Constituents: 68% PBS, 0.03% DTT, 30% Glycerol, 1.17% Sodium chloride

General Info

  • Alternative names
    • Chronic myelogenous leukemia tumor antigen 28
    • CML28
    • EXOS5_HUMAN
    • EXOSC 5
    • Exosc5
    • Exosome complex component rrp46
    • exosome complex exonuclease RRP46
    • Exosome component 5
    • exosome component Rrp46
    • hRrp46p
    • p12B
    • Ribosomal RNA processing protein 46
    • Ribosomal RNA processing protein 46, S. cerevisiae, homolog of
    • Ribosomal RNA-processing protein 46
    • RRP41B
    • RRP46
    • Rrp46p
    see all
  • FunctionNon-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as anti-sense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes.
  • Tissue specificityHighly expressed in a variety of hematopoietic and epithelial tumor cell lines, but not in normal hematopoietic tissues or other normal tissue, with the exception of testis.
  • Sequence similaritiesBelongs to the RNase PH family.
  • Cellular localizationNucleus > nucleolus. Cytoplasm. Nucleus.
  • Information by UniProt

Recombinant Human EXOSC5 protein images

  • 15% SDS-PAGE showing ab124595 (3µg).

References for Recombinant Human EXOSC5 protein (ab124595)

ab124595 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab124595.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"